Concepedia

Yin-Hao Shi

YS

Statistics

Publications

4

Citations

211

H-Index

4

Active since

2022

Affiliations

Sun Yat-sen University(Current)

The First Affiliated Hospital, Sun Yat-sen University

Guangzhou Medical University

Yin-Hao Shi is an author at Sun Yat-sen University specializing in medicine, oncology, and therapeutic resistance mechanisms.

Publications per year

2022–2024

4

Publications

4

METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner

Qiong‐Cong Xu, Yi-Chih Tien, Yin-Hao Shi et al. · Oncogene · 2022 · 130 citations · Full text

, , +15

N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance

Mingjian Ma, Yin-Hao Shi, Zhide Liu et al. · Oncogene · 2024 · 31 citations · Full text

, , +17

Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer

Yin-Hao Shi, Qiong‐Cong Xu, Ying‐Qin Zhu et al. · Molecular Therapy · 2022 · 28 citations · Full text

, , +17

CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy

Zhide Liu, Yin-Hao Shi, Qiong‐Cong Xu et al. · Cancer Letters · 2024 · 22 citations

, , +17

1–4 of 4